Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
28 Cards in this Set
- Front
- Back
- 3rd side (hint)
(1) what is the composition of the pancreas? (2) what cells are in the pancrease?
|
98% exocrine pancreas (acinar cells) & 2% endocrine pancreas (islets of langerhans)
|
alpha (a) cells, beta (B) cells, delta (D) cells, F (PP) cells, epsilon (E) cells
|
|
a cells: (1) hormone (2) function
|
glucagon
|
increase blood glucose levels, promotes glycogenolysis and gluconeogenesis
|
|
B cells: (1) hormone (2) function
|
insulin
|
decreases blood glucose levels, promotes glycogenesis and glycoloysis
|
|
D cells: (1) hormone (2) function
|
somatostatin
|
inhibits endocrine and exocrine pancreatic hormone secretions
|
|
PP cells: (1) hormone (2) function
|
pancreatic polypeptide
|
aids in self-regulation of pancreatic secretions, other function under investigation
|
|
E cells: (1) hormone (2) function
|
grehlin
|
stimulates appetite
|
|
(1) where does insulin come from? (2) how are the products useful?
|
synthesized by B cells from proinsulin > (carboxypeptidase) > insuling (51aa) + C-peptide (31aa)
|
insulins half life = 5min while C-peptide = 30min, so C-peptide can be measured (experimental)
|
|
(1) how does insulin differ between species? (2) which are most similar?
|
highly conserved between species with AA differences in <4 places
|
cat/cow, dog/pig/human
|
|
(1) what induces insulin secretion? (2) what are GLUTs?
|
in response to a rising blood glucose which enters pancratic B cells via facilitated diffusion
|
transporters with specific tissue distributions and response types
|
|
(1) how is insulin prepared? (2) how is insulin secreted?
|
packaged into secretory vesicles & cleaved by carboxypeptidase
|
glucose enters cell via GLUT-2 > glycolysis ? ATP > blocks K+ leak channels > AP > Ca++ into cell > releases insulin from vesicles
|
|
(1) what occurs when insulin is in the blood stream? (2) what is this called?
|
binds insulin receptor > tells GLUT-4 to go to plasma membrane to uptake glucose
|
insulin mediated glucose uptake
|
|
(1) what are the actions of insulin on adipocytes? (2) liver?
|
promotes uptake of glucose (GLUT-4) and synthesis of triglycerides
|
promotes glycolysis and glycogenesis
|
|
(1) what are the actions of insulin on muslce? (2) what happens if you don't have enough insulin acting on cells?
|
promotes uptake (GLUT-4), utilization and storage of glucose
|
diabetes
|
|
What are the types of diabetes?
|
insulin dependent diabetes mellitus (IDDM)
|
non-insulin dependent diabetes mellitus (NIDDM)
|
|
IDDM: (1) cause (2) treatment
|
absolue deficiency of insulin
|
requires exogenous insulin administration
|
|
NIDDM: (1) cause (2) treatment
|
relative deficiency or resistance to endogenous insulin
|
controlled via elimination of obesity, diet modification, oral hypoglycemic agents
|
|
(1) what are the signs of diabetes mellitus? (2) what is diabetic ketoacidosis?
|
polyuria (hyperglycermia leads to spillage of glucose in urine >> osmotic diuresis), polydypsia (loss of excess water via osmotic diuresis stimulates thirst), polyphagia and weight loss (inability to build up glycogen stoers or utilize blood glucose)
|
lack of insulin promotes lipolysis > end product of B-oxidation is ketone bodies (unmeasured organic anions build up in blood > nausea/malaise, acidemia), hyperglycemia = electrolyte/fluid imbalance; requires hospitalization & injectable insulin
|
|
(1) what drugs are used to treat diabetes mellitus?
|
injectable insulin, oral hypoglycemic agents, diet
|
|
|
(1) how is insulin classified? (2) what are the indication for insulin Tx?
|
duration of action (active hormone vs substances hindering absorption: short, intermediat, long), source (human recombinant, synthetic, beef, pork), concentration (40, 100, 500 U/ml; 1 U = 36ug of insulin)
|
diabetes mellitus (IDDM > always, NIDDM > sometimes due to glucose toxicity, DKA > always), ketosis and lipidosis in cattle, and hyperlipidemia in horses
|
|
(1) describe short (rapid) acting insulin?
|
R = regular insulin, most rapid onset (w/in 1/2h), shortest duration of action (up to 8h), only insulin that may be used IV
|
regular insulin
|
|
(2) describe intermediate acting insulin?
|
N = slightly delayed onset (0.5-3hrs), intermediate duration of action (4-24h, but peak at 4-6h, wane ~12h), typically administered SQ BID
|
NPH insulin (Humilin, Novolin) or Lente insulins (Novolin, Vetsulin)
|
|
(1) describe long (slow) acting insulin? (2) brand names?
|
slow onset of action (1-8hr, but peak around 6-12h), long duration of action (2-28h), once to twice daily SQ injections
|
Protamine Zinc Insulin (PZI), Glargine (Lantus), Detemir (Levemir)
|
|
(1) what are adverse reactions to insulin? (2) what drug reactions occur with insulation?
|
antibody formation (switch species, type, etc), hypoglycermia (overdose: roll bottle to mix, don't shake, syringe confusion)
|
antagonize insulin function or inhibit release (glucocorticoids, norepinephrine, dobutamine, thiazide diuretics, Ca channel blockers, progesterone, thyroid hormones, growth hormone) or enhance insulin function or promote release (anabolic steroid, alcohol, beta-blockers, salicylates, tetracyclines, oral hypoglycermics)
|
|
what oral hypoglycemic agents do we use? (2) how does it work?
|
sulfonylurease (glipizide/glyburide)
|
direct blockade of K+ channels leading to insulin release, decreased glucagon levels, improved tissue sensitivity to insulin
|
|
(1) describe glipizide (glucotrol)? (2) describe Glyburide (diabeta, micronase)?
|
readily absorbed from GIT, lasts 10-16h, treat NIDDM, adverse reactions include hepatotoxicity, hypoglycemia, anorexia, vomiting (low rate and reversible)
|
second generation sulfonylurea with a longer duration of action (~24 hours), administered once daily orally, well absorbed from GIT, use and adverse reactions similar to glipizide
|
|
(1) describe biguanides (metformin, phenformin? (2) why use oral hypoglycemics?
|
inhibit hepatic glucose release, improve peripheral insulin sensitivity, promote peripheral utilization of glucose, DOES NOT promote insulin release, adverse reaction of significant lactic acidosis in people
|
treatment of NIDDM; takes a minimum of 3-4 weeks, more effective in cats with moderate preprandial hyperglycermia (<200 mg/dl), can be used in combination with insulin
|
|
(1) how is glucagon used? (2) what is glucagon used for therapeutically?
|
synthesized by a cells of endocrine pancreas, maintains normal concentrations of glucose in blood (opposite of insulin), half life of 3-6min, secretion triggered by hypoglycemia, amino acids, exercise and inhiibted by hyperglycemia
|
adverse reaction treatment to insulin overdose, treatment of an insulinoma tumor
|
|
(1) describe diazoxide?
|
K channel opener, prevents depolarization (inhibit insulin release), expensive
|
|